MedTrace Logo

Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET

NCT03859921 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 716

Last updated 2025-06-12

No results posted yet for this study

Summary

This randomised double-blinded controlled trial aims to compare the live birth rate in natural FET cycles with and without oral dydrogesterone as luteal phase support. The hypothesis is that the use of oral dydrogesterone will increase the live birth rate of natural cycle FET.

Conditions

  • Subfertility

Interventions

DRUG

Dydrogesterone

Progesterone

DRUG

Placebo

Placebo with appearance similar to Dydrogesterone

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Ernest HY Ng, MD · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2025-12-30
Completion
2026-11-30

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03859921 on ClinicalTrials.gov